Investment Company

BB Biotech AG is a corporation listed on the SIX Swiss Exchange, in Germany (Prime Standard) and the "Segmento Star" in Italy and is domiciled in Schaffhausen,
Vordergasse 3. Its business purpose is to invest in biotechnology companies. Asset management, administration and marketing responsibilities have been entrusted to Bellevue Group since the company was founded.

The Board of Directors of BB Biotech AG consists of highly reputable and experienced industry professionals and scientists:

Prof. Dr. Thomas Szucs, Chairman of the Board of Directors
Dr. Clive Meanwell, Member of the Board of Directors
Dr. Erich Hunziker, Member of the Board of Directors

Here you will find all relevant legal documents pertaining to our investment company.

For more information on BB Biotech please visit our website www.bbbiotech.com